Related Experiment Video
Updated: May 30, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Lipids in cystic fibrosis.
Katrin Anne Becker1, Brian Henry, Regan Ziobro
1Department of Molecular Biology, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany.
Cystic fibrosis (CF) lung disease stems from inflammation and infections. Novel research links CF lung issues to altered cell signaling pathways and lipid metabolism, offering new therapeutic targets.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Biochemistry
Background:
- Cystic fibrosis (CF) primarily impacts lungs, leading to inflammation and chronic infections.
- Pulmonary complications significantly affect CF patient quality of life and survival.
- Key pathogens include Pseudomonas aeruginosa, Staphylococcus aureus, Burkholderia cepacia, and Haemophilus influenzae.
Purpose of the Study:
- To explore novel molecular mechanisms underlying pulmonary inflammation and infection susceptibility in cystic fibrosis.
- To investigate the role of specific cellular components and metabolic pathways in CF lung pathology.
Main Methods:
- Review of recent studies on cystic fibrosis pathogenesis.
- Analysis of molecular alterations including death receptors, caveolae proteins, and membrane rafts.
- Examination of ceramide metabolism and prostaglandin levels in CF lungs.
Main Results:
- Alterations in ceramide metabolism (accumulation of ceramide, reduced 15-keto-prostaglandin E2) are implicated in CF lung disease.
- Specific cellular components like death receptors, caveolae proteins, and membrane rafts play a critical role.
- These molecular changes contribute to pulmonary inflammation and increased susceptibility to infection in CF patients.
Conclusions:
- Novel insights suggest that dysregulation of lipid metabolism and specific cell membrane components are central to cystic fibrosis lung pathology.
- Targeting these molecular pathways may offer new therapeutic strategies for managing CF lung disease.
- Further research is needed to fully elucidate the detailed mechanisms involved.
More Related Videos
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
10:18Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells
Published on: June 13, 2019
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Membrane Lipids
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Lysosomal Hydrolases
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...